Connecting Rare Mutations to Common Pathways
- Institution
- Washington University, MO
- Principal investigator
- Jeffrey D Milbrandt
- Funding
- $1.2M
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
Research Project, Project Summary Intellectual and developmental disabilities (IDDs) exact a heavy emotional and financial toll on society, affecting an estimated 1 in 6 children in the US. Developing effective therapeutic interventions to treat IDD is a challenging problem because a large number of environmental and genetic risk factors contribute to these diseases. Indeed, IDD-associated genetic variants have been identified in more than 700 genes, but each variant is present in only a small number of patients, and our understanding of how these variants contribute to the disease is limited. This high degree of genetic heterogeneity and lack of mechanistic insights confound efforts to develop effective therapies to treat IDD. If individual mutations can be grouped by shared molecular pathways, then targeting these pathways may be efficacious in large subsets of patients. The overall goal of our proposal is to develop CRANIUM, a platform that will read out the genomic, transcriptional, and neuronal phenotypic signatures of IDD genes to reveal common pathways disrupted by IDD-associated mutations.
LOADING MOONBASE SCORE
Questions for Washington University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Washington University47
Compromised LDH activity causes motor deficits and hastens ALS progression
Jeffrey D Milbrandt · $635K · 1996–2028
- NIH · Washington UniversityNot yet scored
The role of SARM1 in neuroinflammation-mediated axonal damage
Aaron Diantonio · $551K · 2024–2029
- NIH · Washington UniversityNot yet scored
Multi-omics peripheral nerve atlas enables fine-mapping of pain molecular phenotypes
Jeffrey D Milbrandt · $728K · 2022–2027